• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND INOGEN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND INOGEN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number D143
Device Problems Over-Sensing (1438); Pacing Problem (1439); Pocket Stimulation (1463); Low impedance (2285); Ambient Noise Problem (2877)
Patient Problems Muscle Stimulation (1412); Fainting (1847); Pain (1994)
Event Date 01/16/2018
Event Type  Injury  
Manufacturer Narrative
Additional information concerning this event will be requested from the field.
 
Event Description
Boston scientific received information that this patient was experiencing muscle stimulation and shooting pains into their abdomen due to their implantable cardioverter defibrillator (icd).The patient also reported experiencing issues with fainting.Troubleshooting is ongoing and the icd remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information provided from the field indicated there was oversensing of noise on the right ventricular (rv) channel that caused pacing inhibition with a period of asystole of up to six seconds.The patient was brought back in and surgical intervention was performed to reposition the system.Afterwards the patient was fine.The system remains in service and there were no additional adverse patient effects reported.
 
Event Description
Boston scientific received information that this system was also exhibiting a decrease in shock impedance measurements.No further changes have been made and the system remains in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7350834
MDR Text Key102809026
Report Number2124215-2018-02684
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Patient Family Member or Friend
Type of Report Initial,Followup,Followup
Report Date 03/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/17/2018
Device Model NumberD143
Other Device ID NumberINOGEN EL ICD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received03/26/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/17/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
D143
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-